Apyx Medical Corporation (APYX) DCF Valuation

Apyx Medical Corporation (APYX) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Apyx Medical Corporation (APYX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate Apyx Medical Corporation's (APYX) financial outlook like an expert! This (APYX) DCF Calculator provides pre-filled financial data and full flexibility to modify revenue growth, WACC, margins, and other critical assumptions to align with your projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 28.2 27.7 48.5 44.5 52.3 63.2 76.3 92.1 111.2 134.2
Revenue Growth, % 0 -1.57 75.08 -8.26 17.61 20.72 20.72 20.72 20.72 20.72
EBITDA -19.1 -18.5 -13.9 -22.0 -18.1 -31.2 -37.7 -45.5 -54.9 -66.3
EBITDA, % -67.75 -66.67 -28.66 -49.44 -34.6 -49.43 -49.43 -49.43 -49.43 -49.43
Depreciation .8 .9 .9 .9 .7 1.4 1.7 2.0 2.5 3.0
Depreciation, % 2.68 3.2 1.86 2 1.32 2.21 2.21 2.21 2.21 2.21
EBIT -19.8 -19.4 -14.8 -22.9 -18.8 -32.6 -39.4 -47.6 -57.4 -69.3
EBIT, % -70.43 -69.87 -30.53 -51.44 -35.92 -51.64 -51.64 -51.64 -51.64 -51.64
Total Cash 58.8 41.9 30.9 10.2 43.7 46.8 56.4 68.1 82.2 99.3
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 9.2 17.3 21.2 18.2 14.1
Account Receivables, % 32.75 62.53 43.62 40.99 26.84
Inventories 5.1 4.1 6.8 11.8 9.9 11.6 14.0 16.9 20.5 24.7
Inventories, % 17.94 14.62 13.97 26.5 18.96 18.4 18.4 18.4 18.4 18.4
Accounts Payable 2.4 1.5 2.6 2.7 2.7 3.9 4.7 5.7 6.8 8.2
Accounts Payable, % 8.66 5.45 5.42 6 5.18 6.14 6.14 6.14 6.14 6.14
Capital Expenditure -1.3 -.6 -.7 -1.0 -.5 -1.5 -1.8 -2.1 -2.6 -3.1
Capital Expenditure, % -4.62 -2.1 -1.49 -2.27 -1.02 -2.3 -2.3 -2.3 -2.3 -2.3
Tax Rate, % 12.07 12.07 12.07 12.07 12.07 12.07 12.07 12.07 12.07 12.07
EBITAT -19.6 -11.9 -15.2 -23.3 -16.5 -29.2 -35.3 -42.6 -51.4 -62.1
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -31.9 -19.6 -20.5 -25.4 -10.3 -41.9 -42.4 -51.2 -61.7 -74.5
WACC, % 8.62 7.65 8.65 8.65 8.34 8.38 8.38 8.38 8.38 8.38
PV UFCF
SUM PV UFCF -209.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -76
Terminal Value -1,191
Present Terminal Value -797
Enterprise Value -1,006
Net Debt -5
Equity Value -1,001
Diluted Shares Outstanding, MM 35
Equity Value Per Share -28.91

What You Will Get

  • Real APYX Financial Data: Pre-filled with Apyx Medical’s historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Apyx Medical’s intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • 🔍 Real-Life APYX Financials: Pre-filled historical and projected data for Apyx Medical Corporation (APYX).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) such as WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Apyx Medical’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Apyx Medical’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • 1. Access the Template: Download and open the Excel file featuring Apyx Medical Corporation’s (APYX) preloaded data.
  • 2. Modify Assumptions: Adjust key inputs such as growth rates, WACC, and capital expenditures.
  • 3. Analyze Results Instantly: The DCF model automatically computes intrinsic value and NPV.
  • 4. Explore Scenarios: Evaluate various forecasts to assess different valuation results.
  • 5. Present with Assurance: Deliver professional valuation insights to inform your decisions.

Why Choose Apyx Medical Corporation (APYX)?

  • Innovative Technology: Cutting-edge solutions in the medical device industry enhance patient care.
  • Proven Track Record: A history of successful product launches and satisfied customers.
  • Commitment to Quality: Stringent quality control processes ensure reliable and effective products.
  • Expert Team: A dedicated team of professionals with extensive industry experience drives our success.
  • Strong Market Position: Apyx Medical Corporation (APYX) is recognized for its leadership in advanced surgical technologies.

Who Should Use This Product?

  • Medical Students: Understand advanced medical technologies and their applications using real-world data.
  • Researchers: Integrate cutting-edge medical models into studies or academic projects.
  • Investors: Evaluate your investment hypotheses and assess valuation metrics for Apyx Medical Corporation (APYX).
  • Healthcare Analysts: Enhance your analysis with a customizable financial model tailored for the medical sector.
  • Healthcare Entrepreneurs: Discover how large medical firms like Apyx Medical Corporation (APYX) are evaluated in the market.

What the Template Contains

  • Pre-Filled Data: Contains Apyx Medical Corporation’s historical financials and projections.
  • Discounted Cash Flow Model: An editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC using custom inputs.
  • Key Financial Ratios: Evaluate Apyx Medical Corporation’s profitability, efficiency, and leverage.
  • Customizable Inputs: Easily modify revenue growth, margins, and tax rates.
  • Clear Dashboard: Visuals and tables summarizing key valuation outcomes.

No products were found matching.